Accueil / À propos / Gouvernance / Comité de Formation

Comité de Formation

Le Comité de Formation évalue et recommande des initiatives, y compris, mais sans s’y limiter, des bourses de voyages et de recherche, pour soutenir la mission de formation de GlycoNet. Le association des stagiaires de GlycoNet est composé de personnel hautement qualifié (PHQ) sélectionné par le Comité de Formation et sert de liaison entre le Réseau et la communauté de PHQ.

Membres du Comité


Robert Britton is a Michael Smith Foundation for Health Research Career Scholar and his research program focuses on the concise synthesis of structurally and stereochemically complex natural products and the discovery of new synthetic methods to support drug discovery and development.


Chantelle Capicciotti is a Queen’s National Scholar in Precision Molecular Medicine, jointly appointed in the Departments of Chemistry and Biomedical and Molecular Sciences at Queen’s University. Her research focuses on understanding how glycans/glycoproteins interact with binding-proteins at a cellular level to elicit biological function, and on developing glycan-based approaches for biomarker identification, disease diagnosis, imaging techniques, and cell-based therapies.

John joined Bloom Burton & Co. in January 2012. At Bloom Burton, John’s responsibilities include M&A advisory, licensing advisory and monetization planning, as well as conducting technical and commercial due diligence on companies across all healthcare sectors. John’s area of expertise spans early-stage technologies to profitable healthcare service companies, with a particular focus on preclinical-stage biotech.

Dr. Liu is currently a Principal Scientist with responsibilities in process chemistry development at Gilead Sciences.


Emily Rodrigues is a PhD student in Dr. Matt Macauley’s lab at the University of Alberta. She is the Chair of the GlycoNet Trainee Association Executive Committee. Her project is looking to identify new Siglec ligands and understand how Siglecs control the immune system in both health and disease states.


Warren is a Professor from the Department of Biological Sciences at the University of Alberta. The Wakarchuk lab investigates the structure and function of the enzymes which make and degrade various glycoconjugates. This work has been enabling the chemo-enzymatic synthesis of bioactive glycoconjugates both in the laboratory and for industrial projects. The Wakarchuk lab has expertise with both mammalian and bacterial carbohydrate active enzymes for glycan remodelling applications.


Dr. Williams received her PhD from the University of Guelph in 2013. She completed her postdoctoral fellowship in surgery at Western University and is now an Assistant Professor at UBC Pharmaceutical Sciences.


Elizabeth is the CEO of GlycoNet. She was involved in the GlycoNet initiative since the Letter of Intent stage and served as the Associate Director, Business for the Alberta Glycomics Centre from 2007–2015. Prior to her position with the Centre, she worked as a manager of large-scale and multi-institutional projects with Genome Prairie. In addition to her PhD in biochemistry, Elizabeth has an MBA in biotechnology management.

© Réseau Canadien de la Glycomique (GlycoNet). Tous droits réservés.

Scroll to Top